Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-09 Marriott Tina President and COO Shares withheld for taxes −2,800 $10.09 $28K 645,361
2024-02-09 Marriott Tina President and COO Grant or award · Stock Option (Right to Buy) +447,917 447,917
2024-02-09 Gibson Christopher Chief Executive Officer Grant or award +11,148 785,851
2024-02-09 Gibson Christopher Chief Executive Officer Grant or award +333,449 1,119,300
2024-02-09 Gibson Christopher Chief Executive Officer Shares withheld for taxes −3,233 $10.09 $33K 1,116,067
2024-02-09 Gibson Christopher Chief Executive Officer Grant or award · Stock Option (Right to Buy) +666,898 666,898
2024-02-07 Gibson Christopher Chief Executive Officer Conversion +10,000 801,725
2024-02-07 Gibson Christopher Chief Executive Officer Gift −10,000 791,725
2024-02-07 Gibson Christopher Chief Executive Officer Exercise or conversion +31,250 $2.48 $78K 822,975
2024-02-07 Gibson Christopher Chief Executive Officer Sale −48,272 $9.22 $445K 774,703
2024-02-07 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −31,250 343,750
2024-02-07 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −10,000 6,471,496
2024-02-06 Borgeson Blake Director Sale 10b5-1 −11,447 $9.30 $106K 7,312,917
2024-01-25 Larson Tina Marriott President and COO Exercise or conversion 10b5-1 +8,000 $1.06 $8K 422,584
2024-01-25 Larson Tina Marriott President and COO Sale 10b5-1 −8,000 $10.35 $83K 414,548
2024-01-25 Larson Tina Marriott President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,000 504,000
2024-01-23 Borgeson Blake Director Sale 10b5-1 −20,054 $10.58 $212K 7,324,364
2024-01-17 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 1,006,014
2024-01-17 Secora Michael Chief Financial Officer Sale 10b5-1 −25,000 $10.25 $256K 981,014
2024-01-17 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 1,035,135

Page 25 of 41 · 805 trades